Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Outcomes of Fluoxetine vs EMDR in PTSD
NCT00000379Phase 3Completed
- Sponsor
- Boston University
- Start
- Jan 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoxetine in post-traumatic stress disorder (PTSD), sponsored by Boston University. Started Jan 1999; status: completed.
02
Drugs
fluoxetine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00000379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000379.